drugset / Trial / NCT01069094
A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A study of 3 doses of Progenta versus placebo versus Lucron Depot for treatment of leiomyomata.
Timeline
- Start
- 2004-07
- Primary completion
- 2005-01
- Completion
- 2005-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lucron Depot | Unknown | 3.75 mg | Intramuscular |
| Subject | Telapristone Acetate | Other / unclassified | 12.5 mg | Oral |
| Subject | Telapristone Acetate | Other / unclassified | 25 mg | Oral |
| Subject | Telapristone Acetate | Other / unclassified | 50 mg | Oral |